Deal Announcements

G1 Therapeutics Nets Seed Venture Capital

Friday, September 21, 2012 5:57:00 AM PDT | VentureDeal

Chapel Hill, North Carolina  --  Biotechnology company G1 Therapeutics (no website) has landed $600,000 in early-stage financing.

G1 is a stealth stage company that wants to commercialize technology spun out from UNC-Chapel Hill.

Hatteras Venture Partners made the investment.

The company said it would use the funding to accelerate its drive-development efforts.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1